Last $24.90 USD
Change Today +0.15 / 0.61%
Volume 23.9K
VASC On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 11:38 AM 10/2/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for vascular solutions inc (VASC)

Year over year, Vascular Solutions Inc. has been able to grow revenues from $98.4M USD to $109.2M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to income tax expense from 6.08% to 4.53%. This was a driver that led to a bottom line growth from $9.9M USD to $11.1M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues78.490.098.4109.2
TOTAL REVENUES78.490.098.4109.2
Cost of Goods Sold26.629.832.636.2
GROSS PROFIT51.860.165.873.0
Selling General & Admin Expenses, Total28.429.732.536.4
R&D Expenses13.114.616.217.6
Depreciation & Amortization, Total0.30.81.41.6
OTHER OPERATING EXPENSES, TOTAL41.845.150.255.6
OPERATING INCOME10.115.015.717.4
Interest Expense0.00.00.00.0
Interest and Investment Income0.00.0----
NET INTEREST EXPENSE0.00.00.00.0
Currency Exchange Gains (Loss)0.00.1--0.0
EBT, EXCLUDING UNUSUAL ITEMS10.015.115.717.3
Other Unusual Items, Total3.50.60.2-1.3
Legal Settlements3.5-----1.3
Other Unusual Items--0.60.20.1
EBT, INCLUDING UNUSUAL ITEMS13.615.715.916.1
Income Tax Expense-7.86.06.04.9
Earnings from Continuing Operations21.49.79.911.1
NET INCOME21.49.79.911.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS21.49.79.911.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS21.49.79.911.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VASC:US $24.90 USD +0.15

VASC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $14.10 USD -0.11
Cardiovascular Systems Inc $23.37 USD -1.03
CryoLife Inc $9.87 USD +0.03
Endologix Inc $10.77 USD +0.11
LeMaitre Vascular Inc $6.65 USD -0.0999
View Industry Companies
 

Industry Analysis

VASC

Industry Average

Valuation VASC Industry Range
Price/Earnings 35.3x
Price/Sales 3.6x
Price/Book 4.1x
Price/Cash Flow 30.7x
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VASCULAR SOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.